EC-18: Clinical Trials

5 trials of EC-18, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Not yet recruiting 2
Phase 11Completed 1

Follow EC-18: new trials by email Literature Review of EC-18 trials Research Report on EC-18

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
EC-18, Placebo EC-18 - Atopic Dermatitis
Phase 2Not yet recruitingEnzychem Lifesciences Corporation1502027-05-012026-08-28
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
EC-18, Placebo - Covid19 Pneumonia
Phase 2Not yet recruitingEnzychem Lifesciences Corporation602026-12-302026-10-21
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
EC-18, Placebo EC-18 - COVID-19
Phase 2CompletedEnzychem Lifesciences Corporation632020-05-282022-02-10
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
EC-18, Placebo - Stomatitis
Phase 2CompletedEnzychem Lifesciences Corporation1052018-07-032023-07-27
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
EC-18 - Febrile Neutropenia
Phase 1 / Phase 2CompletedEnzychem Lifesciences Corporation282017-10-302026-11-04

Conditions studied

Breast Neoplasms (1)  ·  COVID-19 (1)  ·  Dermatitis, Atopic (1)  ·  Febrile Neutropenia (1)  ·  Stomatitis (1)

Sponsors

Enzychem Lifesciences Corporation (5)

Countries

South Korea (2)  ·  United States (2)

Top investigators

Dong Moon Shin, MD (1)  ·  Hyewon Jeong (1)  ·  Mahesh Kudrimoti, MD (1)  ·  Sung-Bae Kim, MD, PhD (1)